Temperature Feedback-Controlled Photothermal/Photodynamic/Chemodynamic Combination Cancer Therapy Based On Nagdf4:Er,Yb@Nagdf4:Nd@Cu-Bif Nanoassemblies

Ye Qi,Junwei Ye,Shuangsong Ren,Guangyao Wang,Jialin Lv,Siqi Zhang,Ying Che,Yachen Li,Baojiu Chen,Guiling Ning
DOI: https://doi.org/10.1002/adhm.202001205
IF: 10
2020-01-01
Advanced Healthcare Materials
Abstract:The intelligent design of multifunctional nanoplatforms is critical for cancer therapy. Herein, NaGdF4:Er,Yb@NaGdF4:Nd@Cu(II) boron-imidazolate frameworks (denoted as CSNPs@Cu-BIF) nanoassemblies are designed and fabricated. Upon a single 808 nm laser irradiation, the nanoassemblies not only show the outstanding photothermal conversion capacity (eta = 41.7%) but also generate cytotoxic reactive oxygen species through an in situ Fenton-like reaction and fluorescence resonance energy transfer. Importantly, the nanoassemblies simultaneously introduce remarkable antitumor efficacy via photothermal/photodynamic/chemodynamic combination therapy both in vitro and in vivo. To improve the therapeutic effect of solid tumor ablation, it is highly desirable to monitor the treatment process in real-time. Multiclinical imaging modalities of ultrasonography are employed to systematically investigate the ablation mechanism of solid tumors in vivo. Furthermore, the significant difference between the eigen temperature of CSNPs@Cu-BIF nanoassemblies obtained by the temperature-sensitive emission bands signal changes and the apparent temperature recorded by the thermal imaging camera is 14.55 K at equilibrium. This current work therefore supplies an alternative strategy in temperature feedback-controlled accurate cancer therapy.
What problem does this paper attempt to address?